206 related articles for article (PubMed ID: 15136051)
21. Growth inhibitory activity of indapamide on vascular smooth muscle cells.
Ganado P; Ruiz E; Del Rio M; Larcher F; Sanz M; Steinert JR; Tejerina T
Eur J Pharmacol; 2001 Sep; 428(1):19-27. PubMed ID: 11779033
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor β phosphorylation.
Park ES; Yoo JM; Lim Y; Tudev M; Yoo HS; Hong JT; Yun YP
J Pharmacol Sci; 2011; 116(2):204-13. PubMed ID: 21685708
[TBL] [Abstract][Full Text] [Related]
23. The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways.
Thömmes KB; Hoppe J; Vetter H; Sachinidis A
Exp Cell Res; 1996 Jul; 226(1):59-66. PubMed ID: 8660939
[TBL] [Abstract][Full Text] [Related]
24. The mitogen-activated protein kinase pathway contributes to vanadate toxicity in vascular smooth muscle cells.
Daum G; Levkau B; Chamberlain NL; Wang Y; Clowes AW
Mol Cell Biochem; 1998 Jun; 183(1-2):97-103. PubMed ID: 9655183
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture.
Miyazawa K; Hamano S; Ujiie A
Br J Pharmacol; 1996 Jun; 118(4):915-22. PubMed ID: 8799562
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation.
Lee JJ; Yu JY; Zhang WY; Kim TJ; Lim Y; Kwon JS; Kim DW; Myung CS; Yun YP
Eur J Pharmacol; 2011 Jan; 650(1):342-9. PubMed ID: 21040719
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effect of panaxynol on RASMCs via inhibition of ERK1/2 and CREB.
Jiang LP; Lu Y; Nie BM; Chen HZ
Chem Biol Interact; 2008 Feb; 171(3):348-54. PubMed ID: 18199429
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibition of serum-stimulated responses in vascular smooth muscle cell proliferation by 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone, a newly synthesized 1,4-naphthoquinone derivative.
Kim TJ; Yun YP
Biol Pharm Bull; 2007 Jan; 30(1):121-7. PubMed ID: 17202671
[TBL] [Abstract][Full Text] [Related]
30. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor stimulated vascular smooth muscle cell proliferation and its molecular mechanism.
Li J; Huang SL; Guo ZG
Acta Pharmacol Sin; 2000 Apr; 21(4):340-4. PubMed ID: 11324463
[TBL] [Abstract][Full Text] [Related]
32. Chrysanthemum boreale flower floral water inhibits platelet-derived growth factor-stimulated migration and proliferation in vascular smooth muscle cells.
Kim DY; Won KJ; Yoon MS; Yu HJ; Park JH; Kim B; Lee HM
Pharm Biol; 2015 May; 53(5):725-34. PubMed ID: 25330930
[TBL] [Abstract][Full Text] [Related]
33. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
34. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
35. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
ten Freyhaus H; Huntgeburth M; Wingler K; Schnitker J; Bäumer AT; Vantler M; Bekhite MM; Wartenberg M; Sauer H; Rosenkranz S
Cardiovasc Res; 2006 Jul; 71(2):331-41. PubMed ID: 16545786
[TBL] [Abstract][Full Text] [Related]
36. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells.
Lo HM; Hung CF; Tseng YL; Chen BH; Jian JS; Wu WB
Biochem Pharmacol; 2007 Jun; 74(1):54-63. PubMed ID: 17449016
[TBL] [Abstract][Full Text] [Related]
37. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
38. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
[TBL] [Abstract][Full Text] [Related]
39. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
Campbell M; Trimble ER
Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
Kim TJ; Han HJ; Lim Y; Song MC; Kim J; Hong JT; Yoo HS; Pyo MY; Hwang BY; Lee MK; Yun YP
J Cardiovasc Pharmacol; 2009 Apr; 53(4):341-8. PubMed ID: 19295442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
